# Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

Organization · id `cardio:org-acceleron-pharma-inc-a-wholly-owned-subsidiary-of-merck-co-341e98` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Acceleron+Pharma%2C+Inc.%2C+a+wholly-owned+subsidiary+of+Merck+%26+Co.%2C+Inc.%2C+Rahway%2C+NJ+USA>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) (`cardio:ct-nct03496207`)
- Sponsors: A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR) (`cardio:ct-nct04576988`)
- Sponsors: Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) (`cardio:ct-nct04811092`)
- Sponsors: A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH) (`cardio:ct-nct04896008`)
- Sponsors: A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16) (`cardio:ct-nct04945460`)

## Provenance

Content hash: fe4673c0e94ae6cd53cab67aefc77d6c9303a3837b9e8cf63422d681a5ad3ceb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
